Antihyperalgesic effects of the muscarinic receptor ligand vedaclidine in models involving central sensitization in rats

Pain

Volumn 93, Issue 3, 2001, Pages 221-227

  Shannon, Harlan E ^a   Jones, Carrie K ^a   Li, Dominic L ^a   Peters, Steven C ^a   Simmons, Rosa M A ^a   Iyengar, Smriti ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Antinociception; Muscarinic cholinergic; Rats; Vedaclidine

Indexed keywords

3 (4 BUTYLTHIO 1,2,5 THIADIAZOL 3 YL)QUINUCLIDINE; CAPSAICIN; CARRAGEENAN; CHOLINERGIC RECEPTOR STIMULATING AGENT; FORMALDEHYDE; KETOPROFEN; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RECEPTOR SUBTYPE; SCOPOLAMINE; UNCLASSIFIED DRUG; VEDACLIDINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG POTENTIATION; HYPERALGESIA; MALE; MECHANICAL STIMULATION; NEUROGENIC INFLAMMATION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SENSITIZATION; THERMAL STIMULATION;

EID: 0034891406     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(01)00319-0     Document Type: Article

References (33)

1. The formalin test: Scoring properties of the first and second phases of the pain response in rats
2. Neurogenic hyperalgesia: The search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia
3. Oxotremorine-induced modifications of the behavioral and neuroendocrine responses to formalin in male rats
4. Quantitative assessment of tactile allodynia in the rat paw
5. The formalin test: A validation of the weighted-scores method of the behavioral pain rating
6. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay and physiological dose-response curves
7. Reorganization of spinal cord sensory map after peripheral nerve injury
8. Subcutaneous formalin-induced activity of dorsal horn neurons in the rat: Differential response to an intrathecal opiate administered pre or post formalin
9. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurons
10. Enhanced responses of spinothalamic tract neurons to excitatory amino acids accompany capsaicin-induced sensitization in the monkey
11. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats
12. Enhanced withdrawal responses to heat and mechanical stimuli following intraplantar injection of capsaicin in rats
13. Changes in cholinergic and opioid receptors in the rat spinal cord, dorsal root and sciatic nerve after ventral and dorsal root lesion
14. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
15. Afferent C-fiber and A-delta activity in models of inflammation
16. M2, M3 and M4 but not M1 muscarinic receptor subtypes are present in rat spinal cord
17. Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus
18. Neurogenic hyperalgesia: Psychophysical studies of underlying mechanisms
19. Antinociception after both peripheral and intrathecal injection of oxotremorine is modulated by spinal nitric oxide
20. Intrathecal oxotremorine affects formalin-induced behavior and spinal nitric oxide synthase immunoreactivity in rats
21. Formalin-evoked activity in identified primary afferent fibers: Systemic lidocaine suppresses phase-2 activity
22. Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): A novel analgesic with mixed muscarinic receptor agonist and antagonist activity
23. Modified formalin test: Characteristic biphasic pain response
24. Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat
25. Neurogenic hyperalgesia: Central neural correlates in responses of spinothalamic tract neurons
26. Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammation
27. Butylthio[2.2.2] ((+)-3(R)-[4-(butylthio)-1,2,5-thiadiazol-3-yl]-1-azabicyclo[2.2.2]octane): An antinociceptive orally active muscarinic agonist in mouse and rat
28. Statistical analysis of drug-drug and site-site interactions with isobolograms
29. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans
30. Spinal modulation of the induction of central sensitization
31. The rat paw formalin test: Comparison of noxious agents
32. Evidence for a central component of post-injury hypersensitivity
33. Sensitization of high mechanothreshold superficial dorsal horn and flexor motor neurones following chemosensitive primary afferent activation